Enzyme Catalysis (Michaelis–Menten Kinetics) and Inhibition

An enzyme is a protein — occasionally an RNA — whose folded tertiary structure (the previous chapter's subject) creates an active site precisely shaped and chemically functionalised to accelerate one specific reaction, often by factors of $10^{6}$ to $10^{17}$ relative to the uncatalysed rate. This chapter asks how that acceleration is achieved, and then builds the quantitative language biochemists use to describe it: the Michaelis–Menten equation, the kinetic constants $K_M$ and $V_{\max}$ extracted from it, and the four classical modes of reversible inhibition that perturb those constants in diagnostically distinct ways.

Everything here assumes the vocabulary of the previous chapter — active-site residues are ordinary side chains (frequently histidine, serine, aspartate, cysteine) positioned by tertiary structure — and sets up the language used throughout the rest of this block: every metabolic pathway from Chapter 7 onward is a sequence of enzyme-catalysed steps, each describable by the kinetics developed here.

1. How Enzymes Accelerate Reactions

A catalyst, enzymes included, speeds up a reaction without being consumed and without altering its equilibrium position — it changes only the rate, by providing an alternative reaction pathway of lower activation energy, $E_a$. The equilibrium constant, fixed by the free-energy difference between reactants and products, is completely unaffected: an enzyme accelerates the forward and reverse reactions by the same factor, leaving $K_{eq}$ unchanged.

Several complementary mechanisms, all occurring within the enzyme's active site, together lower $E_a$:

• Proximity and orientation effects. Binding both substrates (for a bimolecular reaction) in the active site raises their effective local concentration enormously and holds them in the correct relative orientation for reaction, saving the large entropic cost that two freely diffusing molecules would otherwise pay to collide productively.
• Stabilisation of the transition state. The active site is shaped to bind the transition state of the reaction more tightly than either the substrate or the product — a principle first articulated by Linus Pauling. Because the transition state is, by definition, the highest-energy point along the reaction coordinate, selectively stabilising it lowers $E_a$ directly.
• Acid–base catalysis. Active-site side chains donate or accept protons at precisely timed steps of the mechanism. Histidine, with its near-neutral side-chain $\text{p}K_a$ (Chapter 1), is especially suited to this role, since it can act as either a general acid or a general base within the physiological pH range.
• Covalent catalysis. A nucleophilic active-site residue (commonly serine's hydroxyl or cysteine's thiol) attacks the substrate directly, forming a transient covalent enzyme–substrate intermediate that is subsequently hydrolysed.
• Metal-ion catalysis. A bound metal cofactor (e.g. $\text{Zn}^{2+}$, $\text{Mg}^{2+}$) can stabilise a developing negative charge, orient a substrate, or participate directly in electron transfer.

Key distinction. A catalyst changes the rate at which equilibrium is reached, never the position of equilibrium itself. An enzyme that is somehow "too effective" cannot push a reaction further than its thermodynamics allow — only faster to the same endpoint.

2. The Enzyme–Substrate Complex and Saturation Kinetics

The starting point of enzyme kinetics is the observation that binding is a discrete chemical step in its own right: the enzyme $E$ and substrate $S$ first combine reversibly into an enzyme–substrate complex, $ES$, which then breaks down to free enzyme and product $P$:

Here $k_1$ and $k_{-1}$ are the forward and reverse rate constants of complex formation, and $k_2$ (also written $k_{\text{cat}}$, the turnover number) is the rate constant of the catalytic step itself. Measuring the initial rate, $v_0$, as a function of substrate concentration $[S]$ (with enzyme held at a fixed, much lower concentration) produces a characteristic curve: $v_0$ rises steeply at low $[S]$, then bends over and approaches a horizontal asymptote at high $[S]$. This asymptotic behaviour is called saturation: once essentially every enzyme molecule is bound as $ES$ at any instant, adding more substrate cannot increase the rate further, because the rate is now limited by how fast $k_2$ can turn over each occupied active site, not by how often $E$ and $S$ collide.

3. Deriving the Michaelis–Menten Equation

The steady-state approximation, introduced by Briggs and Haldane, assumes that shortly after the reaction begins, the concentration of the intermediate $ES$ becomes approximately constant — it is formed and broken down at equal rates — even while $[S]$ and $[P]$ continue to change.

Let $[E_T] = [E] + [ES]$ be the fixed total enzyme concentration, so $[E] = [E_T] - [ES]$. Substituting and solving for $[ES]$:

The combination of rate constants $\dfrac{k_{-1}+k_2}{k_1}$ is defined as the Michaelis constant, $K_M$ — a single composite constant with units of concentration. The initial rate is the rate of product formation, $v_0 = k_2[ES]$, and since $k_2[E_T]$ is the rate obtained when every enzyme molecule is saturated with substrate, this product is defined as $V_{\max}$. Substituting gives the Michaelis–Menten equation:

Definition. $V_{\max} = k_2[E_T]$ is the maximum possible initial rate, approached as $[S] \to \infty$, at a fixed total enzyme concentration. $K_M$ is the substrate concentration at which $v_0 = \tfrac{1}{2}V_{\max}$ — set $[S] = K_M$ in equation (1) and confirm $v_0 = \dfrac{V_{\max}K_M}{K_M+K_M} = \tfrac{1}{2}V_{\max}$.

3.1 Interpreting $K_M$

$K_M$ reduces to the true substrate dissociation constant, $K_d = k_{-1}/k_1$, only in the special case $k_2 \ll k_{-1}$ (the $ES$ complex re-dissociates far more often than it reacts). In general $K_M$ is a composite constant, but it is always, approximately, an inverse measure of an enzyme's affinity for its substrate: a small $K_M$ means the enzyme reaches half-maximal rate at a low substrate concentration (high apparent affinity), while a large $K_M$ means a high substrate concentration is needed (low apparent affinity).

Worked example. An enzyme has $K_M = 2.0\times 10^{-3}~\text{mol}\,\text{dm}^{-3}$ and $V_{\max} = 4.0\times 10^{-6}~\text{mol}\,\text{dm}^{-3}\,\text{s}^{-1}$. Find $v_0$ at $[S] = 8.0\times 10^{-3}~\text{mol}\,\text{dm}^{-3}$.

Substituting directly into equation (1):

This is $80\%$ of $V_{\max}$, consistent with $[S]$ being four times $K_M$: at $[S] = 4K_M$, $v_0 = \dfrac{4K_M}{K_M+4K_M}V_{\max} = \dfrac{4}{5}V_{\max}$.

3.2 The two limiting regimes

Equation (1) contains both halves of the saturation curve as limiting cases:

• At low substrate concentration, $[S] \ll K_M$, the $[S]$ term in the denominator is negligible: $v_0 \approx \dfrac{V_{\max}}{K_M}[S]$, a first-order (directly proportional) dependence on $[S]$ — the steeply rising, near-linear part of the curve.
• At high substrate concentration, $[S] \gg K_M$, the $K_M$ term in the denominator is negligible: $v_0 \approx V_{\max}$, a zero-order dependence on $[S]$ — the flat, saturated plateau.

The ratio $k_{\text{cat}}/K_M$, sometimes called the specificity constant, is the rate constant that governs this low-$[S]$ regime and is widely used to compare an enzyme's catalytic efficiency across different substrates, since it folds both binding affinity and turnover rate into a single number.

4. Linearising the Data: the Lineweaver–Burk Plot

Because $V_{\max}$ is only approached asymptotically, it (and hence $K_M$) is difficult to read accurately off a direct plot of $v_0$ against $[S]$. Taking the reciprocal of both sides of equation (1) produces a linear relationship, the Lineweaver–Burk (double-reciprocal) equation:

Plotting $\dfrac{1}{v_0}$ against $\dfrac{1}{[S]}$ gives a straight line of gradient $\dfrac{K_M}{V_{\max}}$, $y$-intercept $\dfrac{1}{V_{\max}}$, and $x$-intercept $-\dfrac{1}{K_M}$ — three independently extractable quantities from one linear regression, which is precisely why the transformation remains in standard use despite distorting experimental error at low $[S]$ (a limitation noted here but not developed further).

Worked example. Experimental data give a Lineweaver–Burk plot with $y$-intercept $2.5\times 10^{5}~\text{s}\,\text{dm}^{3}\,\text{mol}^{-1}$ and gradient $5.0\times 10^{2}~\text{s}$. Find $V_{\max}$ and $K_M$.

From the $y$-intercept, $\dfrac{1}{V_{\max}} = 2.5\times 10^{5}$, so

From the gradient, $\dfrac{K_M}{V_{\max}} = 5.0\times 10^{2}~\text{s}$, so

These recover exactly the constants used in the previous worked example, as they should.

5. Reversible Enzyme Inhibition

An inhibitor is a molecule that reduces enzyme activity. Reversible inhibitors bind non-covalently and can dissociate, restoring full activity; this section develops the four classical types, each distinguished by where the inhibitor binds and the resulting signature on $K_M$ and $V_{\max}$.

5.1 Competitive inhibition

A competitive inhibitor binds reversibly to the same active site as the substrate, so $E$ and $I$ compete directly for the enzyme: $E + I \rightleftharpoons EI$ (an inactive, non-productive complex), in direct competition with $E + S \rightleftharpoons ES$. Because inhibitor and substrate binding are mutually exclusive, raising $[S]$ sufficiently can always outcompete the inhibitor and still drive the reaction to the same $V_{\max}$ — but a higher $[S]$ is now needed to reach any given fraction of that rate, so the apparent $K_M$ increases.

• $V_{\max}$: unchanged.
• Apparent $K_M$: increased, by the factor $\left(1+\dfrac{[I]}{K_I}\right)$.

5.2 Uncompetitive inhibition

An uncompetitive inhibitor binds only to the $ES$ complex, not to free enzyme — it requires the substrate to be bound first, often because substrate binding exposes or creates the inhibitor's binding site. Because $EIS$ cannot proceed to product, both the effective amount of productive complex and, through a shift in the $E$/$ES$/$EIS$ equilibrium, the apparent affinity are affected — and both $V_{\max}$ and $K_M$ decrease by the same factor, so their ratio $V_{\max}/K_M$ is unchanged.

Here $K_I' = [ES][I]/[EIS]$ is the dissociation constant of the inhibitor from the $ES$ complex.

• $V_{\max}$: decreased.
• Apparent $K_M$: decreased, by the same factor.

5.3 Non-competitive inhibition

A non-competitive inhibitor binds equally well to free enzyme $E$ or to the $ES$ complex, at a site distinct from the active site (an allosteric site) — binding is independent of whether substrate is already bound. In the simplest ("pure") case the inhibitor binds $E$ and $ES$ with identical affinity, lowering the concentration of catalytically competent complex without affecting substrate binding itself.

• $V_{\max}$: decreased.
• Apparent $K_M$: unchanged.

5.4 Mixed inhibition

Mixed inhibition is the general case: the inhibitor binds both $E$ and $ES$, but with different affinities ($K_I \neq K_I'$). Pure non-competitive inhibition is the special case $K_I = K_I'$; both $V_{\max}$ and apparent $K_M$ change, but not necessarily by the same factor, so their ratio does change (unlike the uncompetitive case).

Key distinction. The diagnostic question for any reversible inhibitor is twofold: does it bind free enzyme, the $ES$ complex, or both — and does raising $[S]$ ever fully overcome it? Competitive inhibition is overcome at high $[S]$ (unchanged $V_{\max}$); the other three types are not (all decrease $V_{\max}$), because they remove active enzyme by a route substrate concentration cannot reverse.

Worked example. An enzyme has $K_M = 2.0\times 10^{-3}~\text{mol}\,\text{dm}^{-3}$ and $V_{\max} = 4.0\times 10^{-6}~\text{mol}\,\text{dm}^{-3}\,\text{s}^{-1}$ in the absence of inhibitor. A competitive inhibitor is added at a concentration such that $[I]/K_I = 3.0$. Find the apparent $K_M$ and the new $v_0$ at $[S] = 8.0\times 10^{-3}~\text{mol}\,\text{dm}^{-3}$.

The apparent $K_M$ is scaled by $\left(1+\dfrac{[I]}{K_I}\right) = 1+3.0 = 4.0$:

$V_{\max}$ is unaffected, so substituting into equation (1) with $K_M^{\text{app}}$:

The rate has fallen from $3.2\times 10^{-6}$ (Section 3.1, no inhibitor) to exactly half of $V_{\max}$ — sensible, since $[S]$ now equals $K_M^{\text{app}}$ exactly.

6. Irreversible Inhibition

An irreversible inhibitor forms a stable covalent bond with the enzyme (typically with a catalytic residue in the active site), permanently inactivating it. Unlike reversible inhibition, activity cannot be restored by removing excess inhibitor or raising $[S]$; the only way to regain activity is to synthesise new enzyme molecules. Organophosphate nerve agents and many pesticides act this way, covalently phosphorylating the catalytic serine of acetylcholinesterase and permanently blocking neurotransmitter breakdown — the mechanistic basis of their toxicity, and a clinical contrast worth holding against the four reversible mechanisms above.

7. Common Exam Pitfalls

• Treating $K_M$ as a binding constant in general. $K_M$ equals the true dissociation constant $K_d$ only when $k_2 \ll k_{-1}$; in general it is the composite $\dfrac{k_{-1}+k_2}{k_1}$ and should be described as an apparent measure of affinity, not binding affinity itself.
• Confusing a small $K_M$ with a slow enzyme. $K_M$ describes affinity (where on the $[S]$ axis half-saturation occurs), while $V_{\max}$ (or $k_{\text{cat}}$) describes the speed of the catalytic step. The two are independent: an enzyme can have very high affinity (small $K_M$) yet a low turnover number.
• Forgetting that $V_{\max}$ depends on enzyme concentration. $V_{\max} = k_{\text{cat}}[E_T]$ is not an intrinsic property of the enzyme alone; doubling $[E_T]$ doubles $V_{\max}$, while $K_M$ and $k_{\text{cat}}$ themselves are unaffected.
• Assuming every inhibitor lowers $V_{\max}$. Competitive inhibition leaves $V_{\max}$ unchanged precisely because sufficient substrate can always outcompete the inhibitor; only inhibitors that bind somewhere substrate cannot displace them from (uncompetitive, non-competitive, mixed) reduce $V_{\max}$.
• Mixing up which constant increases and which decreases. Competitive: $K_M^{\text{app}}$ up, $V_{\max}$ same. Uncompetitive: both down, by the same factor. Non-competitive: $V_{\max}$ down, $K_M$ same. Mixed: both change, by different factors. Re-derive the direction from first principles (does raising $[S]$ overcome the inhibitor?) rather than memorising a table blindly.
• Treating reversible and irreversible inhibition as the same phenomenon. Reversible inhibition is described by an equilibrium constant $K_I$ and is overcome by removing the inhibitor; irreversible inhibition is a permanent covalent modification, quantitatively described by a rate of inactivation, not an equilibrium constant.

Summary

• Enzymes lower $E_a$ via proximity/orientation effects, transition-state stabilisation, acid–base catalysis, covalent catalysis and metal-ion catalysis, without altering $K_{eq}$.
• The Michaelis–Menten equation, $v_0 = \dfrac{V_{\max}[S]}{K_M+[S]}$, follows from the steady-state approximation applied to $E+S \rightleftharpoons ES \to E+P$.
• $K_M = \dfrac{k_{-1}+k_2}{k_1}$ is the substrate concentration giving half-maximal rate, an inverse measure of apparent affinity; $V_{\max} = k_{\text{cat}}[E_T]$ is the rate at saturating substrate.
• The Lineweaver–Burk linearisation, $\dfrac{1}{v_0} = \dfrac{K_M}{V_{\max}}\cdot\dfrac{1}{[S]}+\dfrac{1}{V_{\max}}$, extracts $K_M$ and $V_{\max}$ from a straight-line fit.
• Competitive inhibition raises apparent $K_M$, leaves $V_{\max}$ unchanged; uncompetitive lowers both by the same factor; non-competitive lowers $V_{\max}$, leaves $K_M$ unchanged; mixed changes both, by different factors.
• Irreversible inhibitors covalently and permanently inactivate the enzyme, unlike any of the four reversible modes above.
• The next chapter turns from protein catalysts to the carbohydrates — monosaccharides, disaccharides and polysaccharides — that are frequently the substrates these enzymes act upon.